Bioera Statistics

Total Valuation

Bioera has a market cap or net worth of EUR 1.31 million. The enterprise value is 3.93 million.

Market Cap	1.31M
Enterprise Value	3.93M

Important Dates

The next estimated earnings date is Friday, September 6, 2024.

Earnings Date	Sep 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Bioera has 20.57 million shares outstanding.

Shares Outstanding	20.57M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.26%
Owned by Institutions (%)	1.26%
Float	15.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.72
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.81
EV / Sales	8.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.22

Current Ratio	0.22
Quick Ratio	0.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19.51

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-49.43%
Return on Capital (ROIC)	n/a
Revenue Per Employee	112,250
Profits Per Employee	-1.22M
Employee Count	4
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.72% in the last 52 weeks. The beta is 1.14, so Bioera's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-28.72%
50-Day Moving Average	0.07
200-Day Moving Average	0.06
Relative Strength Index (RSI)	42.89
Average Volume (20 Days)	34,763

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioera had revenue of EUR 449,000 and -4.87 million in losses. Loss per share was -0.40.

Revenue	449,000
Gross Profit	-274,000
Operating Income	-3.10M
Pretax Income	-4.99M
Net Income	-4.87M
EBITDA	-3.10M
EBIT	-3.10M
Loss Per Share	-0.40

Balance Sheet

The company has 435,000 in cash and 3.01 million in debt, giving a net cash position of -2.58 million or -0.13 per share.

Cash & Cash Equivalents	435,000
Total Debt	3.01M
Net Cash	-2.58M
Net Cash Per Share	-0.13
Equity (Book Value)	-5.23M
Book Value Per Share	-0.44
Working Capital	-5.84M

Cash Flow

Operating Cash Flow	-630,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-61.02%
Operating Margin	-690.87%
Pretax Margin	-1,112.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioera does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-630.80%
FCF Yield	n/a

Stock Splits

The last stock split was on November 28, 2022. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 28, 2022
Split Type	Reverse
Split Ratio	0.1